Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 5;6(1):dlad154.
doi: 10.1093/jacamr/dlad154. eCollection 2024 Feb.

Successful prophylaxis of ESBL Enterobacteriaceae repetitive urinary tract infections with subcutaneous temocillin: a case report

Affiliations

Successful prophylaxis of ESBL Enterobacteriaceae repetitive urinary tract infections with subcutaneous temocillin: a case report

Eloïse Delpierre et al. JAC Antimicrob Resist. .

Abstract

Objectives: Temocillin is an antibiotic belonging to the β-lactam family, introduced in 1988 but soon forgotten because of its narrow spectrum. Recently, it has been repurposed for its effectiveness against ESBL Enterobacteriaceae, and represents an alternative of choice to carbapenems due to its limited impact on the microbiota.

Patient: We present here a successful case of antibiotic prophylaxis of recurrent ESBL urinary tract infections with subcutaneously administered temocillin.

Conclusions: Temocillin is rarely administered subcutaneously and even more rarely in prophylactic situations. However, its tolerance profile and low impact on the microbiota should help reconsideration of its use in particular cases like this one.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Two years of infections in our 51-year-old patient. The upper part lists infections with ESBL-producing organisms; the lower part lists those with non-ESBL-producing organisms. The left part lists infections 1 year before the introduction of temocillin; the right part lists those 1 year after the introduction of temocillin.

References

    1. WHO . Antibiotic resistance. 2023. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance.
    1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629–55. 10.1016/S0140-6736(21)02724-0 - DOI - PMC - PubMed
    1. Farfour E, Dortet L, Guillard T et al. Antimicrobial resistance in Enterobacterales recovered from urinary tract infections in France. Pathogens 2022; 11: 356. 10.3390/pathogens11030356 - DOI - PMC - PubMed
    1. Lekkas A, Gyi KM, Hodson ME. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis. J Cyst Fibros 2006; 5: 121. 10.1016/j.jcf.2005.12.005 - DOI - PubMed
    1. HAS. Avis de la commission de transparence. 2015. https://www.has-sante.fr/upload/docs/evamed/CT-14132_NEGABAN_PIC_INS_Avi....

LinkOut - more resources